The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors
Open accessAbstract
BACKGROUND: The effective management of fatigue in patients with cancer requires a clear delineation of what constitutes nontrivial fatigue. The authors defined numeric cutpoints for fatigue severity based on functional interference and described the prevalence and characteristics of fatigue in patients with cancer and survivors. METHODS: In a multicenter study, outpatients with breast, prostate, colorectal, or lung cancer rated their fatigue severity and symptom interference with functioning on the M. D. Anderson Symptom Inventory numeric scale of 0 to 10. Ratings of symptom interference guided the selection of numeric rating cutpoints between mild, moderate, and severe fatigue levels. Regression analysis identified significant factors related to reporting moderate/severe fatigue. RESULTS: The statistically optimal cutpoints were ≥ 4 for moderate fatigue and ≥ 7 for severe fatigue. Moderate/severe fatigue was reported by 983 of 2177 patients (45%) undergoing active treatment and was more likely to occur in patients receiving treatment with strong opioids (odds ratio [OR], 3.00), those with a poor Eastern Cooperative Oncology Group performance status (OR, 2.00), those who had > 5% weight loss within 6 months (OR, 1.60), those who were receiving > 10 medications (OR, 1.58), those with lung cancer (OR, 1.55), and those with a history of depression (OR, 1.42). Among survivors (patients with complete remission or no evidence of disease, and not currently receiving cancer treatment), 29% of patients (150 of 515 patients) had moderate/severe fatigue that was associated with poor performance status (OR, 3.48) and a history of depression (OR, 2.21). CONCLUSIONS: The current study statistically defined fatigue severity categories related to significantly increased symptom interference. The high prevalence of moderate/severe fatigue in both actively treated patients with cancer and survivors warrants the promoting of the routine assessment and management of patient‐reported fatigue. Cancer 2014;120:425–432. © 2013 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-79 · Cited by 2,856
Serlin, R. C., Mendoza, T. R., Nakamura, Y., Edwards, K. R., & Cleeland, C. S. (1995) · Pain · doi:10.1016/0304-3959(94)00178-h · Cited by 1,494
Self-citationAssessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory
Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., & Engstrom, M. C. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v · Cited by 1,360
Self-citationFatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.743 · Cited by 1,134
Fatigue in cancer patients compared with fatigue in the general United States population
Cella, D., Lai, J., Chang, C., Peterman, A., & Slavin, M. (2002) · Cancer · doi:10.1002/cncr.10245 · Cited by 841
Self-citationCella, D., Davis, K., Breitbart, W., Curt, G., & Coalition, F. T. F. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3385 · Cited by 652
Self-citationThe Missing Voice of Patients in Drug-Safety Reporting
Basch, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp0911494 · Cited by 646
Panel, N. I. O. H. S.-O.-T.-S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg014 · Cited by 398
(2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/djg014 · Cited by 395
A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn250 · Cited by 283
Troublesome Symptoms in Cancer Survivors: Fatigue, Insomnia, Neuropathy, and Pain
Pachman, D. R., Barton, D. L., Swetz, K. M., & Loprinzi, C. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.7238 · Cited by 282
Oldenmenger, W. H., de Raaf, P. J., de Klerk, C., & van der Rijt, C. C. D. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.06.007 · Cited by 270
The course of severe fatigue in disease‐free breast cancer patients: a longitudinal study
Servaes, P., Gielissen, M. F. M., Verhagen, S., & Bleijenberg, G. (2007) · Psycho-Oncology · doi:10.1002/pon.1120 · Cited by 234
Jean‐Pierre, P., Morrow, G. R., Roscoe, J. A., Heckler, C., Mohile, S., Janelsins, M., Peppone, L., Hemstad, A., Esparaz, B. T., & Hopkins, J. O. (2010) · Cancer · doi:10.1002/cncr.25083 · Cited by 191
Principles and Practice of Palliative Care and Supportive Oncology
Berger, A. M., Shuster, J. L., & Roenn, J. H. V. (2012) · Cited by 188
Moraska, A. R., Sood, A., Dakhil, S. R., Sloan, J. A., Barton, D., Atherton, P. J., Suh, J. J., Griffin, P. C., Johnson, D. B., Ali, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1444 · Cited by 175
Yanez, B., Pearman, T., Lis, C. G., Beaumont, J. L., & Cella, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mds539 · Cited by 160
Self-citationHowell, D., Keller–Olaman, S., Oliver, T. K., Hack, T. F., Broadfield, L., Biggs, K., Chung, J., Gravelle, D., Green, E., Hamel, M., et al. (2013) · Current Oncology · doi:10.3747/co.20.1302 · Cited by 158
ASCPRO Recommendations for the Assessment of Fatigue as an Outcome in Clinical Trials
Barsevick, A. M., Cleeland, C. S., Manning, D. C., O’Mara, A. M., Reeve, B. B., Scott, J. A., & Sloan, J. A. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.02.006 · Cited by 150
Self-citationCancer patients' expectations of experiencing treatment‐related side effects
Hofman, M., Morrow, G. R., Roscoe, J. A., Hickok, J. T., Mustian, K. M., Moore, D. F., Wade, J. L., & Fitch, T. R. (2004) · Cancer · doi:10.1002/cncr.20423 · Cited by 143
Given, B. A., Given, C. W., Sikorskii, A. E., Jeon, S., McCorkle, R. C., Champion, V. L., & Decker, D. A. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.03.012 · Cited by 123
Hirschfeld, G. H. F., & Zernikow, B. (2012) · Pain · doi:10.1016/j.pain.2012.10.008 · Cited by 121
Role of cutpoints: why grade pain intensity?
Anderson, K. O. (2004) · Pain · doi:10.1016/j.pain.2004.10.024 · Cited by 72
Minton, O., Strasser, F., Radbruch, L., & Stone, P. C. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.03.025 · Cited by 55
Impact of Cultural and Linguistic Factors on Symptom Reporting by Patients With Cancer
Wang, X. S., Cleeland, C. S., Mendoza, T. R., Yun, Y. H., Wang, Y., Okuyama, T., & Johnson, V. E. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq097 · Cited by 53
Self-citationCut-points for the measurement of pain: The choice depends on what you want to study
Farrar, J. T. (2010) · Pain · doi:10.1016/j.pain.2010.03.013 · Cited by 31
The rapid assessment of fatigue severity in cancer patients
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990301)85:5 · Cited by 1
Self-citation
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Cancer-Related Fatigue, Version 2.2015
Berger, A. M., Mooney, K., Alvarez-Perez, A., Breitbart, W. S., Carpenter, K. M., Cella, D., Cleeland, C., Dotan, E., Eisenberger, M. A., Escalante, C. P., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0122 · Cited by 949
Self-citationAmerican Cancer Society Colorectal Cancer Survivorship Care Guidelines
El‐Shami, K., Oeffinger, K. C., Erb, N. L., Willis, A., Bretsch, J. K., Pratt‐Chapman, M. L., Cannady, R. S., Wong, S. L., Rose, J., Barbour, A. L., et al. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21286 · Cited by 475
Cancer-Related Fatigue: Causes and Current Treatment Options
Thong, M. S. Y., van Noorden, C. J. F., Steindorf, K., & Arndt, V. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-0707-5 · Cited by 438
Cancer-related fatigue and associated disability in post-treatment cancer survivors
Jones, J. M., Olson, K., Catton, P., Catton, C. N., Fleshner, N. E., Krzyzanowska, M. K., McCready, D. R., Wong, R. K. S., Jiang, H., & Howell, D. (2016) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0450-2 · Cited by 334
Metadata
- Authors
- Wang, X. S., Zhao, F., Fisch, M. J., O'Mara, A. M., Cella, D., Mendoza, T. R., & Cleeland, C. S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2013-11-05
- Volume
- 120
- Issue
- 3
- Pages
- 425-432
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1499455897
- Cited by
- 369
- References
- 27
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.